Quality of Life and Experience of Patients with Heart Failure with Preserved Ejection Fraction and Their Caregivers
Raül Rubio, Beatriz Palacios, Luis Varela, Martín Gutiérrez Ibañez, Selene Camargo Correa, Elena Calvo Barriuso, Nuria José, Sergi Yun Viladomat, María Teresa Soria Gómez, Esther Montero Hernández, Encarna Hidalgo, Cristina Enjuanes, Yolanda Rueda, Maite San Saturnino

TL;DR
This study explores how heart failure with preserved ejection fraction affects patients' and caregivers' quality of life and healthcare experiences in Spain.
Contribution
The study provides new insights into the qualitative and quantitative impacts of HFpEF on quality of life and caregiving roles.
Findings
HFpEF significantly impacts patients' and caregivers' quality of life.
Qualitative findings reveal discrepancies between patient-reported outcomes and perceived quality of life.
Multidisciplinary care is increasingly valued by patients and caregivers.
Abstract
Background/Objectives: Evidence of patient experiences with heart failure with preserved ejection fraction (HFpEF) and disease impact on quality of life (QoL) is scarce. This study explored perceived impacts on QoL and healthcare experiences of HFpEF patients and their caregivers. Methods: This was a mixed-methods study with HFpEF patients, ≥40 years, New York Heart Association functional classes I-IV in Spain. Qualitative data were collected through semi-structured interviews with patients (n = 19) and caregivers (n = 17). The EuroQoL 5D-5L, Patient Global Impression of Severity, and Kansas City Cardiomyopathy Questionnaire were used to collect QoL measures. Results: The themes were as follows. (1) Impact of HFpEF on QoL; (2) new roles of informal caregiving; and (3) the increasing value of multidisciplinary care. Qualitative data were supported by a trend of worsening QoL on…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHeart Failure Treatment and Management · Cardiovascular Function and Risk Factors
